Histone H4 acetylation by immunohistochemistry and prognosis in newly diagnosed adult acute lymphoblastic leukemia (ALL) patients

Histone H4 acetylation by immunohistochemistry and prognosis in newly diagnosed adult acute lymphoblastic leukemia (ALL) patients

<p>Abstract</p> <p>Background</p> <p>Histone deacetylase (HDAC) inhibitors are a novel anti-tumor therapy. To determine whether HDAC inhibitors may be useful in the treatment of adult acute lymphoblastic leukemia (ALL), we examined the acetylation of histone H4 by immun...

Full description

Bibliographic Details
Main Authors: Sekeres Mikkael, Sobecks Ronald, Copelan Ed, Zhao Xiaoxian, Kalaycio Matt, Jin Tao, Douglas Elizabeth, Gibson Sarah E, Advani Anjali S, Sungren Shawnda, Hsi Eric D
Format: Article
Language:English
Published: BMC 2010-07-01
Series:BMC Cancer
Online Access:http://www.biomedcentral.com/1471-2407/10/387

Internet

http://www.biomedcentral.com/1471-2407/10/387

Similar Items